Sanofi Forecast, price target & analysts
Sanofi Target price 2026 - Analyst rating & recommendation
Sanofi Classifications & Recommendation
Sanofi Price Target
| Target Price | €95.37 |
| Price | €74.05 |
| Potential |
28.79%
register free of charge
|
| Number of Estimates | 28 |
|
28 Analysts have issued a price target Sanofi 2027 .
The average Sanofi target price is €95.37.
This is
28.79%
register free of charge
€117.60
58.81%
register free of charge
€57.57
22.26%
register free of charge
|
|
| A rating was issued by 30 analysts: 17 Analysts recommend Sanofi to buy, 12 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sanofi stock has an average upside potential 2027 of
28.79%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion € | 46.72 | 49.50 |
| 5.49% | 5.97% | |
| EBITDA Margin | 24.56% | 30.73% |
| 3.19% | 25.13% | |
| Net Margin | 16.72% | 20.61% |
| 33.21% | 23.23% |
26 Analysts have issued a sales forecast Sanofi 2026 . The average Sanofi sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an Sanofi EBITDA forecast 2026. The average Sanofi EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
26 Sanofi Analysts have issued a net profit forecast 2026. The average Sanofi net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 6.37 | 8.52 |
| 44.12% | 33.75% | |
| P/E | 8.70 | |
| EV/Sales | 2.17 |
26 Analysts have issued a Sanofi forecast for earnings per share. The average Sanofi EPS is
This results in the following potential growth metrics and future valuations:
Current Sanofi Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| TD COWEN |
Locked
➜
Locked
|
Locked | Jul 14 2026 |
| ROTHSCHILD & CO REDBURN |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| DAY BY DAY |
Locked
➜
Locked
|
Locked | Jul 12 2026 |
| BANCO SANTANDER |
Locked
➜
Locked
|
Locked | Jul 08 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 01 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jul 01 2026 |
| INTESA SANPAOLO EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jun 30 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
TD COWEN:
Locked
➜
Locked
|
Jul 14 2026 |
|
Locked
ROTHSCHILD & CO REDBURN:
Locked
➜
Locked
|
Jul 13 2026 |
|
Locked
DAY BY DAY:
Locked
➜
Locked
|
Jul 12 2026 |
|
Locked
BANCO SANTANDER:
Locked
➜
Locked
|
Jul 08 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 01 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jul 01 2026 |
|
Locked
INTESA SANPAOLO EQUITY RESEARCH:
Locked
➜
Locked
|
Jun 30 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
